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n transformed cells, induction of apoptosis by adenovirus
type 2 (Ad2) early region 4 ORF 4 (E4orf4) correlates with
accumulation of E4orf4 in the cell membrane–cytoskeleton
fraction. However, E4orf4 is largely expressed in nuclear
regions before the onset of apoptosis. To determine the
relative contribution of nuclear E4orf4 versus membrane-
associated E4orf4 to cell death signaling, we engineered
green ﬂuorescent fusion proteins to target E4orf4 to speciﬁc
cell compartments. The targeting of Ad2 E4orf4 to cell
membranes through a CAAX-box or a myristylation consensus
signal sufﬁced to mimic the fast Src-dependent apoptotic
program induced by wild-type E4orf4. In marked contrast,
the nuclear targeting of E4orf4 abolished the early induction
I
 
of extranuclear apoptosis. However, nuclear E4orf4 still
induced a delayed cell death response independent of
Src-like activity and of E4orf4 tyrosine phosphorylation.
The zVAD.fmk-inhibitable caspases were dispensable for
execution of both cell death programs. Nevertheless, both
pathways led to caspase activation in some cell types
through the mitochondrial pathway. Finally, our data support
a critical role for calpains upstream in the death effector
pathway triggered by the Src-mediated cytoplasmic death
signal. We conclude that Ad2 E4orf4 induces two distinct
cell death responses, whose relative contributions to cell
killing may be determined by the genetic background.
 
Introduction
 
Adenovirus type 2 (Ad2)* early region 4 ORF 4 (E4orf4) is a
small 14-kD Ad protein that may play multiple roles during
Ad infection (Muller et al., 1992; Kleinberger and Shenk,
1993; Bondesson et al., 1996; Estmer Nilsson et al., 2001).
In mammalian cell lines, expression of Ad2 E4orf4 triggers a
p53-independent cell death program which is selective to
transformed cells (Shtrichman et al., 1999; unpublished
data). Thus, uncovering the molecular mechanisms involved
in E4orf4-mediated death may help in deciphering the cellular
components linking cell division to cell death programs and
unravel novel strategies for tumor therapy.
Early work in mammalian cells revealed that cell death
induced by Ad2 E4orf4 is associated with classic apoptotic hall-
marks, including nuclear condensation, cell shrinkage, and
externalization of phosphatidylserines (Lavoie et al., 1998).
Nevertheless, activation of the zVAD.fmk-inhibitable caspases
is not required for execution of the death program in most cell
types (Lavoie et al., 2000; Livne et al., 2001; unpublished data).
E4orf4 binding to the B
 
 
 
 subunit of protein phosphatase
(PP)2A was linked to cell death induction in mammalian
cells (Shtrichman et al., 1999; Marcellus et al., 2000), and to
induction of irreversible growth arrest in yeast (Kornitzer et
al., 2001; Roopchand et al., 2001). However, the exact
mechanisms  involved remain ill defined. In addition, these
studies indicated that extra functions are required for cell
killing,  and furthermore, that a PP2A/Cdc55-independent
function also exists. Recently, Ad2 E4orf4 was found to in-
duce a Src-mediated cytoplasmic apoptotic signal requiring
the tyrosine phosphorylation of E4orf4, which rapidly leads
to caspase-independent membrane blebbing and cell death
(Lavoie et al., 2000; Gingras et al., 2002). Analysis of E4orf4
distribution in various cell lines revealed that the protein is
first expressed preferentially in nuclear regions; however,
induction of early membrane blebbing correlates with rapid
accumulation of E4orf4 in cytoplasmic membrane regions.
In the present study, we provide strong evidence that both
the cytoplasmic membrane-associated and the nuclear
E4orf4 induce specific cell death programs in human trans-
formed cells. Our data indicate that the cell death programs
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induced by the differentially localized E4orf4 proteins are asso-
ciated with distinct morphological features and kinetics and in-
volve different death effector pathways.
 
Results
 
Expression of Ad2 E4orf4 in cell membranes is 
sufficient to trigger a cytoplasmic death signal
 
When expressed in mammalian cells, Ad2 E4orf4 shows a
typical nucleocytoplasmic distribution and the onset of ex-
tranuclear apoptosis correlates with its accumulation in the
cytoplasm and membranes (Fig. 1 A) (Lavoie et al., 2000;
Gingras et al., 2002). To address the significance of the
nuclear versus the cytoplasm membranes distribution of
E4orf4 for its killing function, E4orf4-GFP proteins were
engineered to target or enrich the protein in the different cell
compartments, using specific targeting sequences (nuclear
exclusion signal [NES], CAAX, myristylation [Myr], NLS)
as described in Materials and methods (Fig. 1 B). The
blebbing-inducing activity in live cells and the appearance of
nuclear condensation were measured in cells expressing
comparable levels of the E4orf4 proteins in the proper cell
compartments, in the three transformed cell lines 293T,
293, and C-33A. As expected, the GFP control proteins did
not induce membrane blebbing or nuclear condensation
over a period of 3 d (Figs. 1 C and 2; see Table II). Remark-
ably, overexpression of the E4orf4-GFP-NES or the mem-
brane-anchored E4orf4-GFP proteins (E4orf4-GFP-CAAX
and Myr-GFP-E4orf4) induced membrane blebbing to
equivalent or even higher efficiency relative to the wild-type
(WT) E4orf4-GFP protein (Fig. 2 A; Table I). Furthermore,
nuclear condensation typical of that induced by WT E4orf4
was triggered by the cytoplasmic and membrane-anchored
E4orf4 proteins (Fig. 2 A; Table II). In contrast, the nuclear
E4orf4 (E4orf4-GFP-NLS) did not lead to early induction
of membrane blebbing. Nevertheless, nuclear condensation
was induced by E4orf4-GFP-NLS, but cell death was mark-
edly delayed relative to that induced by WT and membrane-
associated E4orf4-GFP (Fig. 2 A; Table II). Thus, the results
strongly suggest that membrane-associated E4orf4 directly
signals membrane blebbing followed by rapid cell death, and
that nuclear E4orf4 in¬duces a distinct death process.
 
The cytoplasm membrane–associated and the nuclear 
Ad2 E4orf4 death activities are distinct
 
Recent work indicated that Src-regulated Ad2 E4orf4 phos-
phorylation is a prerequisite for induction of the cytoplasmic
death signal (Gingras et al., 2002). To delineate the mecha-
nisms involved in induction of cell death mediated by the
different E4orf4-GFP proteins, we looked at the effect of ty-
rosine phosphorylation of E4orf4. We used a previously
characterized nonphosphorylatable E4orf4 (3Y-F)-GFP, in
which tyrosine 26, 42, and 59 are replaced by phenylala-
nines; this mutant was found to accumulate to higher levels
in the cell nucleus (Gingras et al., 2002). As shown previ-
ously, apoptosis induced by mutant E4orf4 (3Y-F)-GFP
was severely impaired in 293T cells (Table II). In 293 and
Figure 1. GFP fusions and protein targeting. (A) Immunostaining of 
transfected E4orf4 protein in H1299 cells using rabbit anti-2418 E4orf4 
antibody (Lavoie et al., 2000); C, cell cytoplasm of a blebbing cell; 
N, nucleus. (B) GFP and E4orf4-GFP constructs engineered to target 
proteins to the cytoplasm (NES), to cell membranes (CAAX and Myr), 
and to the nucleus (NLS). (C) In vivo localization of GFP control 
proteins expressed in 293T cells (confocal micrographs). Protein 
targeting efficiencies were evaluated 24 h after transfection by counting 
positive cells expressing the GFP proteins in the targeted cell compart-
ment, by fluorescence microscopy in live cells, n   600. Bars, 10  m.
 
Table I. 
 
Targeting efficiencies and blebbing-inducing activities of the E4orf4-GFP proteins
Constructs 293T
Targeting
C-33A
Targeting
C-33A
Blebbing
293
Targeting
293
Blebbing
 
% cells
 
E4orf4-GFP N 
 
 
 
 35 – 61 N 
 
 
 
 42 39
E4orf4-GFP-NLS N 
 
 
 
 94 N 
 
 
 
 65 18 N 
 
 
 
 91 3
E4orf4-GFP-NES C 
 
  
 
92 – – – –
E4orf4-GFP-CAAX M 
 
  
 
96 M 
 
  
 
93
 
 
 
55 M 
 
  
 
92 76
Myr-GFP-E4orf4 M 
 
  
 
33
 
 
 
–– – –
 
n
 
 
 
 
 
 850
 
n
 
 
 
 
 
 600
 
n
 
 
 
 
 
 500
 
n
 
 
 
 
 
 150
Transfection of the indicated GFP constructs was performed in 293T, 293, and C-33A, and the protein targeting efficiencies and blebbing-inducing activities
(percentage blebbing) were determined by fluorescence microscopy in live cells 24 h after transfection; C, cytoplasmic; M, cell membranes; N, nuclear.  
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Figure 2. Functional activities of the 
E4orf4-GFP proteins. (A) 293T cells 
were transfected with the indicated 
Flag-E4orf4-GFP constructs (WT, NLS, 
NES, CAAX, and Myr), or with the relevant 
Flag-GFP controls (GFP, GNLS, GNES, 
GCAAX, and MyrG). At various times after 
transfection, the amounts of GFP-positive 
cells undergoing membrane blebbing 
were determined by fluorescence 
microscopy in live cells. Data are 
expressed as percent blebbing cells 
relative to the total number of GFP-
positive cells. Other cultures of transfected 
cells were fixed and counterstained with 
DAPI and the nuclear morphology of 
GFP-positive cells was analyzed by 
fluorescence microscopy (representative 
phenotypes are shown). Apoptosis was 
determined by counting the number of 
cells expressing the relevant GFP proteins 
strictly in the targeted cell compartments 
that presented nuclear shrinkage and 
condensation (arrows). Data are expressed 
as the number of apoptotic cells relative 
to the total number of GFP-positive 
(means   SE of at least four independent 
experiments, n   2,000). Bars, 10  m. 
(B) Aliquots of transfected cells were kept 
for Western blot analyses of expression 
levels using anti-Flag M2 antibody, or 
anti-GFP, 16–24 h after transfection.
 
Table II. 
 
The tyrosine phosphorylation of Ad2 E4orf4 regulates its cytoplasmic membrane activity but not its nuclear activity
Constructs C-33A 293T 293
NL Apoptosis NL Apoptosis NL Apoptosis
 
% cells
 
24 h 48 h 48 h 72 h 24 h
 
GFP – 10 8 – 4 – – 9
GFP-NLS 69 5 4 76 3 4 – 11
GFP-CAAX
 
 
 
11 1 1 3 1 7– – 7
orf4-GFP 29 37 56 35 56 – 42 37
3YF-GFP 64 21 41 77 13 26 – 20
orf4-GFP-NLS 65 14 34 94 – 33 92 21
3YF-GFP-NLS 92 17 34 91 – 30 – –
orf4-GFPCAAX 2 39 51 2 42 – – 48
3YF-GFPCAAX 9 13 16 19 14 – – 10
 
n
 
 
 
  
 
600
 
n
 
 
 
  
 
900
 
n
 
 
 
  
 
600
 
n
 
 
 
  
 
900
 
n
 
 
 
  
 
500
 
n
 
 
 
  
 
1,000
293T, 293, and C-33A cells were transfected with the indicated GFP constructs; (3Y-F), nonphosphorylated mutant E4orf4. At the indicated times after
transfection, cells were fixed and DNA was labeled with DAPI. Protein targeting efficiencies and apoptotic activities (nuclear condensation and
fragmentation) were evaluated by fluorescence microscopy and are expressed as the percentage of nuclear localization (NL), or the percentage of apoptosis,
relative to the total number of GFP-positive cells. Data are the means 
 
  
 
SE of four independent experiments. 
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C-33A cells, apoptosis induced by the nonphosphorylatable
E4orf4 was also delayed, but reached comparable levels later
on. Notably, E4orf4 phosphorylation was not required to
drive its nuclear activity, as the nuclear targeting of the non-
phosphorylatable E4orf4 (E4orf4 [3Y-F]-GFP-NLS) did not
affect its apoptotic activity relative to the WT E4orf4-GFP-
NLS, or to the parental nonphosphorylatable E4orf4. Fur-
thermore, the nonphosphorylatable membrane-anchored
E4orf4 protein (E4orf4 [3Y-F]-GFP-CAAX) was completely
deficient, indicating that expression of Ad2 E4orf4 in the
cell nucleus is required to trigger the Src-independent cell
death signal. As another approach, we measured the effects
of a kinase-deficient c-src and of a selective Src family kinase
inhibitor, SU6656 (Blake et al., 2000), on apoptosis in-
duced by both pathways. In agreement with our previous
findings, overexpression of kinase-deficient c-src markedly
inhibited the appearance of nuclear condensation in cells ex-
pressing the WT E4orf4-GFP (Lavoie et al., 2000) and a
similar effect was measured in presence of SU6656 (Fig. 3).
Importantly, these treatments also inhibited apoptosis in-
duced by the E4orf4-GFP-CAAX, but not apoptosis in-
duced by the nuclear E4orf4 (E4orf4-GFP-NLS). This con-
firmed that the nuclear death pathway induced by E4orf4
was distinct from the Src-regulated cytoplasmic pathway.
 
Caspase activation by Ad2 E4orf4 is dispensable for 
execution of both cell death programs
 
Our previous work indicates that apoptosis mediated by Ad2
E4orf4 is resistant to caspase inhibition (Lavoie et al, 1998,
2000; unpublished data); however, inhibition of E4orf4-
induced nuclear condensation by caspase inhibitors was re-
ported in 293T cells (Livne et al., 2001). Thus, we read-
dressed this question by looking at apoptosis induced by both
E4orf4-dependent cell death pathways in presence and ab-
sence of two different broad-spectrum cell-permeable irrevers-
ible caspase inhibitors, zVAD.fmk and BocD.fmk. In 293T
cells, no significant inhibition of nuclear condensation was
detected in cells expressing either of the E4orf4-GFP pro-
teins, even when zVAD.fmk or BocD.fmk were added back
every 24 h (Fig. 4 A). Moreover, no activation of the effector
caspase-3 was detected in the apoptotic condensed cells, when
using a specific antibody against the activated/cleaved form of
caspase-3 (Fig. 4 C; Table III). In marked contrast, high levels
of active caspase-3 were detected in 293T cells overexpressing
Bax-GFP. Because DNA fragmentation was observed along
with nuclear condensation in C-33A, but not in 293 and
293T cells (Fig. 4 C, compare c with f), these experiments
were repeated in C-33A cells. Not surprisingly, BocD.fmk
and zVAD.fmk potently inhibited DNA fragmentation in
cells expressing the various E4orf4-GFP proteins (Fig. 4 B).
However, caspase inhibitors had a very different effect in
these cells when compared with Fas- or Bax-expressing cells.
Indeed, caspase inhibition decreased the overall number of
apoptotic cells expressing Fas or Bax by 70% to 50%, respec-
tively, whereas no protection was observed in E4orf4-express-
ing cells. In fact, the overall number of apoptotic cells was not
diminished and inhibition of DNA fragmentation was associ-
ated with increased nuclear condensation (Fig. 4 B). Addi-
tionally, high levels of active caspase-3 were detected, but only
in those cells presenting the fragmented phenotype; active
caspase-3 was completely absent in condensed cells (in pres-
ence of caspase inhibitors), thus reproducing the apoptotic
process observed in 293T cells (Fig. 4 C; Table III). A similar
switch of apoptotic phenotypes was observed in C-33A cells
coexpressing E4orf4 and dominant negative caspase-9, or
Bcl-2, but not by treatment with caspase-8 inhibitor (zIETD-
fmk) (Figs. 4 B and 5). Thus, caspase-dependent DNA frag-
mentation and activation of the effector caspase-3 were likely
triggered through activation of the mitochondria–apopto-
some pathway in C-33A cells, but not in 293T cells.
Figure 3. Role of Src kinases in regulation of both cell death 
pathways. 293T, 293, and C-33A cells were transfected with the 
indicated E4orf4-GFP constructs with or without c-src (K295R). The 
Src inhibitor SU6656 was added at a concentration of 1  M 6 h 
after the transfection. Apoptosis was evaluated after cell fixation and 
DAPI staining, couple to immunostaining of c-src (K295R). Data are 
expressed as the percent inhibition of apoptosis (of apoptotic nuclei) 
relative to cells expressing equivalent levels of E4orf4-GFP proteins 
only (means   SE of two independent experiments). Aliquots of 
transfected cells were kept for Western blot analyses of E4orf4-GFP 
(anti-Flag M2) and c-src (K295R) (anti–v-src Ab1). The effect of 
SU6656 was determined only in those cells expressing equivalent 
levels (intensity) of GFP proteins in presence and absence of the 
inhibitor and data are representative of two independent experiments, 
n   800. Bar, 10  m. 
 
 
Two death pathways induced by Ad2 E4orf4 |
 
 Robert et al. 523
 
Calpains are involved in execution of the Src-regulated 
death pathway induced by Ad2 E4orf4
 
Because overexpression of the antiapoptotic protein Bcl-2 did
not inhibit the caspase-independent nuclear condensation
induced by the various E4orf4-GFP proteins in either 293T
or C-33A (Fig. 5), we envisioned that execution of E4orf4-
Figure 4. Effect of caspase inhibitors and caspase activation in cells expressing E4orf4-GFP proteins. (A and B) 293T and C-33A cells were 
transfected with the indicated E4orf4-GFP constructs in presence or absence of different caspase inhibitors (as indicated), or cotransfected 
with dominant-negative caspase-9 (C9DN) at a plasmid DNA ratio of 1:2. As controls, cells were transfected with Fas or Bax-GFP or incubated 
in presence of puromycin (10  g/ml). Cells were fixed at various times after transfection; 24 (puro, Fas, Bax-GFP), 48 h (WT, NES, CAAX in 
293T and C-33A; NLS in C-33A), or 72 h (NLS in 293T). The number of apoptotic nuclei (% apoptosis) was determined after DAPI staining. 
(A) Data are expressed as percent inhibition of apoptosis relative to untreated cells (DMSO only) and are the means   SE of three independent 
experiments, n   500. Aliquots of transfected cells were kept for Western blot analysis of E4orf4-GFP proteins using anti-Flag M2 (insert). 
(B) Apoptosis is expressed as the number of cells presenting DNA fragmentation (black bars), or nuclear condensation (gray bars) relative to 
the total number of transfected cells expressed relative to untreated cells empty vector (EV) (cells expressing E4orf4-GFP proteins alone). Data 
are representative of three independent experiments (means   SE, BocD.fmk, n   1,000); zIETD.fmk, n   200; C9DN, n   350. (C) 293T or 
C-33A cells transfected with E4orf4-GFP were fixed at 24 (C-33A) or 48 h (293T) after transfection, and endogenous active caspase-3 was 
detected in single cells by immunolabeling using anti-cleaved caspase-3 (Asp175) and DNA was labeled with DAPI. C, nuclear condensation; 
f, DNA fragmentation. Bars, 10  m. 
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mediated death involves some nonmitochondrial death effec-
tors. Indeed, analysis of the subcellular distribution of mito-
chondrial proapoptotic factors confirmed that expression of
E4orf4-GFP led to the release of both cytochrome c and ap-
optosis-inducing factor (AIF) in the cytosol of C-33A cells.
However, overexpression of Bcl-2, a critical regulator of the
permeabilization of the outer mitochondrial membrane (for
review see Martinou and Green, 2001), inhibited their re-
lease, although no effect was observed on the overall level of
apoptosis (unpublished data). Thus, AIF, a mediator of
caspase-independent cell death (for review see Daugas et al.,
2000), is likely not required for execution of either caspase-
independent death pathways induced by Ad2 E4orf4. In
marked contrast, we found that overexpression of calpastatin,
the endogenous inhibitor of calpains that binds to the acti-
vated calpain as a suicide substrate (for review see Donkor,
2000), dramatically inhibited the caspase-independent apop-
tosis induced by the WT and membrane-anchored E4orf4-
GFP proteins (60–80% inhibition; Fig. 6). Relatively, over-
expression of the calpain inhibitor had little effect on apopto-
sis induced by the nuclear and the nonphosphorylatable
E4orf4-GFP (
 
 
 
30% inhibition), or on that induced by Bax-
GFP that was completely inhibitable by coexpression of Bcl-2
(Fig. 5). Thus, the results strongly suggest that calpains are
playing a critical role upstream in execution of the Src-regu-
lated cytoplasmic death pathway, but not in the Src-indepen-
dent nuclear death pathway induced by Ad2 E4orf4, which
likely involve other nonmitochondrial death effectors.
 
Discussion
 
The cytoplamic membrane and the nuclear 
localization of Ad2 E4orf4 are both relevant to its 
killing function
 
When expressed in mammalian cells, Ad2 E4orf4 distributes
in both the cell nucleus and the cytoplasm and membranes.
The nuclear accumulation of Ad2 E4orf4 is regulated at the
molecular level through a stretch of basic residues spanning
amino acids 68–75 (KRRDRRRR) that serves as an NLS (un-
published data), whereas its cytoplasmic accumulation likely
results from a passive diffusion out of the nucleus. Indeed, the
 
Table III. 
 
Analysis of activated caspase-3 in cells expressing E4orf4-GFP proteins
C-33A 293T
Caspase 3   Apoptosis Caspase 3  Apoptosis
 
 
 
 
 
% cells 
 
 
 
% cells
 
% cells
 
 
 
zVAD
 
 
 
zVAD % cells
 
 
 
zBocD
 
 
 
BocD
 
GFP 7
 
b
 
7 6 0.2
 
c
 
23
E4orf4-GFP 24
 
b
 
33 38 0.8
 
c
 
52 48
GFP-CAAX 7
 
b
 
10 8 0.4
 
c
 
56
E4orf4-GFP-CAAX 24
 
b
 
34 32 2.4
 
c
 
40 41
GFP-NLS 12
 
b
 
10 9 1.0
 
d
 
23
E4orf4-GFP-NLS 23
 
b
 
23 20 – – –
3YF-GFP-NLS – – – 2.1
 
d
 
27 34
Bax-GFP 93
 
a
 
98 51 80.0
 
a
 
100 21
 
n
 
 
 
  
 
350
 
n
 
 
 
  
 
500
 
a
 
Cells fixed at 24 h.
 
b
 
Cells fixed at 36 h.
 
c
 
Cells fixed at 48 h.
 
d
 
Cells fixed at 72 h.
Apoptosis was determined from the total number of E4orf4-expressing cells with apoptotic nuclei (including condensed “c” or fragmented “f”, Fig. 4 C) and
the percentages of apoptotic cells showing positive staining for active caspase-3 (Caspase-3 [+]) were determined in absence and presence (data not shown)
of caspase inhibitors. Data are representative of at least two independent experiments. 
Figure 5. Caspase-independent apoptosis induced by E4orf4-GFP 
proteins is not inhibited by Bcl-2. 293T and C-33A were transfected 
with the indicated E4orf4-GFP constructs alone, or with an HA-Bcl-2 
construct using a plasmid DNA ratio of 1:1. The percentages of 
apoptotic cells were determined after cell fixation and immuno-
detection of Bcl-2 using mouse anti-HA antibody followed by DAPI 
staining in cells expressing E4orf4-GFP proteins (EV), as compared 
with cells coexpressing E4orf4-GFP and HA-Bcl-2 (Bcl-2). Data are 
representative of at least three independent experiments. 
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cytoplasmic distribution of the protein is not affected by lep-
tomycin B, an inhibitor of the CRM1-mediated nuclear ex-
port pathway (Ossareh-Nazari et al., 1997; unpublished data).
It has been suggested that E4orf4 binding to Src kinases fol-
lowed by tyrosine phosphorylation inhibits the nuclear import
of E4orf4 and promotes its cytoplasmic retention (Gingras et
al., 2002). Because the onset of the apoptotic response medi-
ated by E4orf4 correlates better with its accumulation in the
cell cytoplasm membranes, the relevance of E4orf4 nuclear lo-
calization for cell killing is somewhat unclear. Surprisingly,
E4orf4 targeting to different cell compartments has uncovered
a delayed novel killing function associated with its nuclear lo-
calization. This approach also confirmed that the presence of
E4orf4 in the cell cytoplasm membranes is necessary and suf-
ficient for triggering the Src-regulated cytoplasmic death sig-
nal that rapidly leads to cell death. Several observations indi-
cated that the cell death pathway induced by nuclear E4orf4 is
functionally distinct. When expressed in 293T, C-33A, or
293 cells, the E4orf4-GFP-NLS was mainly nuclear in the
majority of cells over a period of 3 d. Presumably, the strong
NLS from large T antigen took over the natural molecular de-
terminants of Ad2 E4orf4 localization and allowed for contin-
ual import of the fusion protein into the cell nucleus, at least
in the cell types used. In these cells, the onset of apoptosis was
not associated with a dramatic extranuclear apoptotic phase
(early membrane blebbing), did not require tyrosine phos-
phorylation of E4orf4 nor Src kinase activity, and was mark-
edly delayed relative to the cytoplasmic Src-regulated cell
death pathway. Furthermore, inhibition of calpains had little
effect on apoptosis induced by the nuclear and nonphosphory-
latable E4orf4 proteins, whereas it dramatically inhibited the
caspase-independent apoptosis mediated by the membrane-
anchored E4orf4. Although fluorescence microscopy is not sen-
sitive enough to exclude the possibility that small amounts of
E4orf4-GFP-NLS may accumulate in the cytoplasm to some
extent, altogether, these mechanistic data strongly support the
existence of two distinct E4orf4-mediated cell death pathways
and make it very unlikely that delayed apoptosis resulted from
protein leakage out of the nucleus.
Figure 6. Inhibition of E4orf4-mediated caspase-independent 
apoptosis by calpastatin. Cells were transfected with the Bax-GFP 
or E4orf4-GFP constructs alone, or together with a HA-calpastatin 
construct at a plasmid DNA ratio of 1:2, in the presence of caspase 
inhibitor (C-33A). The percentages of apoptotic cells were determined 
in cells expressing E4orf4 or Bax proteins alone (EV), as compared 
with cells coexpressing the GFP proteins and HA-calpastatin, after 
cell fixation and immunodetection of the exogenous calpastatin using 
mouse anti-HA followed by DAPI staining. Data are representative 
of two independent experiments (means   SE, C-33A, n   700).
Figure 7. Working model for the mechanisms of Ad2 E4orf4–
induced cell death. Based on the results obtained in the present 
study and those reported before (Shtrichman et al., 1999; Lavoie et 
al., 2000; Marcellus et al., 2000; Estmer Nilsson et al., 2001; Gingras 
et al., 2002), we propose that Ad2 E4orf4 triggers two distinct cell 
death pathways that do not require caspase activation for execution, 
but can connect to the intrinsic caspase-activating pathway in 
competent cells (e.g., C-33A cells). One is initiated from the cytoplasm 
membranes and involves some calpain activity; another is signaled 
from the cell nucleus and relies on unknown mitochondrial-
independent death effector (see Discussion for details).526 The Journal of Cell Biology | Volume 158, Number 3, 2002
Toward a better understanding of Ad2 E4orf4–mediated 
cell death
As summarized in a working model (Fig. 7), we propose
that Ad2 E4orf4 triggers two caspase-independent cell death
programs that rely on distinct death effectors for execution,
which can connect to the mitochondrial caspase-activating
pathway in competent cells. An Src-regulated death path-
way requires E4orf4 accumulation in the cell cytoplasm
membranes and involves calpains. A distinct Src-indepen-
dent death signal results from E4orf4 accumulation in the
cell nucleus and is mediated by unknown nonmitochondrial
death effectors. We believe that the contribution of either
pathway to cell death will be determined by the availability
of specific targets of Ad2 E4orf4 and the activity of signaling
pathways involved in a given transformed cell types (e.g.,
Src kinases). Accordingly, the low killing efficacy of the nu-
clear E4orf4 in 293T relative to 293 cells may result from a
decreased accessibility of some critical nuclear target of
E4orf4, which may be sequestered by simian virus large T
antigen. Whatever the case, the contribution of Src kinases
and the role of E4orf4 tyrosine phosphorylation have been
firmly assigned exclusively to regulation of the cytoplasmic
pathway. It remains to be determined whether PP2A is in-
volved in the Src-regulated cytoplasmic, and/or the nuclear
cell death pathways mediated by E4orf4, and whether the
tumor-selective killing of Ad2 E4orf4 can be assigned to one
specific pathway or both. Nevertheless, the data obtained
using E4orf4 as a model system suggest that specific modu-
lation of Src family kinases may induce efficient tumor-
selective calpain-regulated cell death.
The results obtained clearly establish that the general
caspase pathways (the extrinsic and intrinsic pathways) are
dispensable for execution of both death processes induced
by Ad2 E4orf4. Even caspase-2, a more atypical caspase
does not appear to play a role in either pathway (no inhibi-
tion using specific caspase-2 inhibitor; unpublished data).
Our results are in contradiction with another study show-
ing a critical role for caspase-8 in 293T cells (Livne et al.,
2001). The reasons for this discrepancy are unknown, but
could relate to clonal cell variability and culture conditions.
Based on our data, we rather believe that caspase activation
through the intrinsic-mitochondrial pathway more gener-
ally serves to accelerate and amplify the apoptotic responses
induced by E4orf4 in cell types more competent to apopto-
sis induction (e.g., C-33A). In fact, in C-33A cells express-
ing E4orf4, caspase inhibition (using caspase inhibitors,
Bcl-2, or dominant-negative caspase-9) did not change the
overall rate of apoptosis but only switched the apoptotic
phenotype toward pure caspase-independent nuclear con-
densation, like the apoptotic response observed in 293 or
293T cells. In these cells transformed with viral oncogenes,
the overexpressed Bcl-2 functional homologue E1B-19K
could be responsible for the lack of caspase activation in re-
sponse to E4orf4 (White et al., 1992). Thus, both the cyto-
plasmic and the nuclear death pathways induced by E4orf4
rather rely on other caspase- and mitochondria-indepen-
dent execution processes.
Finally, using the highly specific endogenous calpain in-
hibitor, calpastatin, we obtained strong evidence that some
calpain activity is critical for execution of the Src-dependent
cytoplasmic death pathway, but not as such for the nuclear
pathway. As suggested in other systems, calpains may con-
nect E4orf4 signaling (both the cytoplasmic and nuclear) to
the mitochondrial pathway via regulation of the proapoptotic
activity of some Bcl-2 family, thus amplifying the release
of mitochondrial factors leading to caspase-dependent and
-independent cell death (Wood et al., 1998; Gao and Dou,
2000; Chen et al., 2001; Gil-Parrado et al., 2002; Mandic et
al., 2002). Whatever the case, calpains appear to serve a criti-
cal function for execution of the cytoplasmic death pathway
mediated by E4orf4. E4orf4-Src–mediated calpain activation
(either via protein phosphorylation and/or calcium transient)
may be critical for triggering actin remodeling and polymer-
ization required for dynamic apoptotic membrane blebbing.
Calpain activation by v-src is believed to promote focal ad-
hesion disruption, loss of substrate adhesion and migration
of v-src–transformed cells (Carragher et al., 2002). In-
deed, calpains are Ca
2 -dependent intracellular proteases that
cleave substrate proteins localized near the membranes and
cytoskeleton in a limited manner, and may thus act to regu-
late protein functions like caspases (for review see Glading et
al., 2002). Additionally, some proteins involved in motility
and adhesion are substrates for both calpains and caspases
(e.g., FAK, actin, and cortactin), and some of these proteins
are also substrates of Src (for review see Tatosyan and Mizen-
ina, 2000), whose phosphorylation is modulated by E4orf4
expression (positively and negatively for cortactin and FAK,
respectively) (Lavoie et al., 2000). Interestingly, changes in
tyrosine phosphorylation can modify susceptibility of some
substrates to calpain, suggesting that a specific modulation of
Src couple to calpain activation could function coordinately
in initiation of the cytoplasmic death pathway mediated by
E4orf4 (Huang et al., 1997). Alterations of the actin poly-
merization status could then directly induce apoptosis (Rao
et al., 1999). For instances, disinhibition of DNase I (which
binds to actin) is associated with actin hyperpolymerization
in posttraumatic apoptotic cell death, and human DNase I
family endonucleases can play a role in apoptotic cell death
programs (Kayalar et al., 1996; Villa et al., 1998; Bareyre et
al., 2001; Oliveri et al., 2001; Shiokawa and Tanuma, 2001).
In future work, we hope to clarify the mechanisms that may
mediate calpain activation by E4orf4-Src signaling and the
downstream events that trigger caspase-independent and
-dependent apoptotic alterations.
Materials and methods
Expression vectors and mutagenesis
The Flag-E4orf4-GFP and Flag-E4orf4 (3Y-F)-GFP were described previ-
ously (Gingras et al., 2002). The expression vectors Flag-GFP-NLS, which
contain the NLS from SV40 large T antigen (PKKKRKKV) (Kalderon et al.,
1984) and the Flag-GFP-NES, containing the leucine-rich nuclear export
signal from REV-1 (LPPLERLTL) (Fischer et al., 1995), were described previ-
ously (Lee et al., 1999) and were obtained from Dr. Stephen Lee (McGill
University, Montréal, Québec, Canada). The Flag-GFP-CAAX contains a
COOH terminus CAAX-box from ras (CMSCKCVLS) (Ruta et al., 1986) and
was obtained by inserting a peptide sequence coding for the CAAX-box
with cohesive extensions into EcoRI-EcoRV sites of the Flag-GFP vector. To
generate the Flag-E4orf4-GFP constructs, Ad2 E4orf4 sequence was ampli-
fied by the PCR method using an HA-E4orf4/PUHD10-3 as the template as
described (Gingras et al., 2002) and inserted into ApaI-XhoI sites of the
Flag-GFP vectors. The Flag-E4orf4 (3Y-F)-GFP-NLS and Flag-E4orf4 (3Y-F)-
CAAX were obtained using the same method except that Flag-E4orf4 (3Y-F)
was used as the template. The Myr-GFP construct containing the Myr con- Two death pathways induced by Ad2 E4orf4 | Robert et al. 527
sensus signal from chicken c-src (MGSSKSK) (Resh, 1999) was generated by
standard PCR method and subcloned into the EGFP-C1 expression vector
(CLONTECH Laboratories). The Myr-GFP-HA-E4orf4 construct was gener-
ated by digesting pHAO4 hygromycin (unpublished data) to obtain HA-
tagged E4orf4, which was subcloned into the ecl136II site of Myr-GFP. The
cDNA coding for dominant-negative caspase-9 was obtained from Dr. Y.A.
Lazebnik (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY) (Fearn-
head et al., 1998) and was subcloned into the pCI-neo-myc expression vec-
tor. The human HA-tagged calpastatin cDNA (Hitomi et al., 1998) was
subcloned into the pCI-neo expression vector (Invitrogen). The human HA-
tagged Bcl-2 was a gift from Dr. G.C. Shore (McGill University, Montréal,
Québec, Canada) and was described previously (Nguyen et al., 1994). The
chicken c-src(K295R) in pLNCX vector was provided by Dr. J.S. Brugge
(Harvard Medical School, Boston, MA) and was described previously (Thomas
et al., 1991). Human Fas in pCI-neo and human Bax in pEGFP-C3 vector
were described previously (Wolter et al., 1997; Charette et al., 2000).
Cell culture and transfection
293 cells were derived from human embryonic kidney cells and express
Ad5 E1A and E1B proteins and so are 293T cells that also express large T
antigen (Graham et al., 1977). Human C-33A (American Type Culture Col-
lection HTB-31) are from cervical carcinoma and are deficient for p53 ex-
pression. 293 and 293T were maintained in DME and C-33A were culture
in  -modified Eagle medium, both supplemented with 10% fetal bovine
serum and streptomycin sulfate-penicillin (100 U/ml). Transfections were
performed by the calcium phosphate method as described (Gingras et al.,
2002). Transfections were processed during 5 to 6 h in presence of chloro-
quine (25  M for 293T and 50  M for 293 and C-33A; Sigma-Aldrich).
Cotransfection of E4orf4 constructs with HA-Bcl2, dominant-negative
caspase-9, or HA-calpastatin were performed using a plasmid DNA ratio
of 1:1, or 1:2, in 5–7  g total plasmid DNA. For all experiments using
293T and C-33A, the cells were seeded on polylysine-coated culture
dishes as described previously (Lavoie et al., 2000).
In vivo localization, morphological assays, and 
apoptosis assays
Live cells expressing the various GFP fusion proteins were observed using a
Nikon TE-300 inverted microscope equipped with a  60 0.85 MA objec-
tive. Images were captured as 16-bit TIFF files with a Micromax 1300YHS
(B/W) cooled CCD camera ( 30 C; Princeton Instruments) driven by Meta-
morph software version 4.5 (Universal Imaging Corp.). Confocal micros-
copy was performed using a Bio-Rad MRC-1024 imaging system mounted
on a Nikon Diaphot-TMD equipped with a  20 objective lens. The
blebbing-inducing activity was measured in live cells, and apoptosis was
determined after cell fixation by analyzing the nuclear morphology as de-
scribed (Gingras et al., 2002). Aliquots of transfected cells were kept for
Western blot analysis of protein expression. The broad spectrum caspase
inhibitors, z-Val-Ala-Asp-(Ome)-CH2F (zVAD.fmk), Boc-Asp-(OMe)-CH2F
(BocD.fmk), and the caspase-8 inhibitor II, z-IETD-fmk (z-Ile-Glu[Ome]-
Thr-Asp[Ome]-CH2F; Calbiochem) were dissolved at 50 mM in DMSO,
and were added to the cell cultures during and after transfection at a con-
centration of 75  M; fresh inhibitors were added back every 24 h. Immu-
nodetection was performed as described (Lavoie et al., 2000). At the indi-
cated times, cells were washed in PBS containing 1 mM MgCl2, fixed in
3.7% formaldehyde/PBS for 20 min and postfixation was performed in ice-
cold 70% ethanol for 12 h at 4 C. Immunofluorescence analyses were per-
formed using the following antibodies: chicken c-src (K295R) was revealed
using rabbit anti-SRC2 antibody (Santa Cruz Biotechnology); rabbit anti-
GFP was used occasionally to label the GFP fusion proteins (ClONETECH
Laboratories, Inc.); active caspase-3 was revealed with rabbit anticleaved
caspase-3 (Asp175) antibody (Cell signaling; NEB); cytochrome c was re-
vealed using mouse anti-cytochrome c (clone 6H2.B4; Pharmingen); AIF
was monitored using a rabbit anti-AIF antibody raised against a COOH-ter-
minal peptide (LNEVAKLFNIHED) and was a gift from Dr. J Landry (Laval
University, Québec, Canada), followed by either ALEXA-594- or ALEXA-
488-labeled goat anti–rabbit, or anti–mouse immunoglobulin G (Molecular
Probes). DNA was labeled using DAPI (Molecular Probes).
Western blotting
Cells were washed in PBS and lysed in SDS sample buffer (Lavoie et al.,
2000). Equal amounts of total cell proteins (determined using the Bio-Rad
Dc Protein Assay) were loaded in SDS-PAGE gels (12% acrylamide) and
transferred onto nitrocellulose membrane. Blots were developed with
mouse monoclonal anti-Flag M2 (Sigma-Aldrich), mouse Ab-1 anti–v-src
(Calbiochem; Novabiochem), or mouse HA.11 anti-HA antibody (BabCO).
Horseradish peroxidase–linked goat anti–mouse immunoglobulin G (Jack-
son ImmunoResearch Laboratories), revealed by the enhanced chemilumi-
nescence detection system (Renaissance; NEN Life Science Products) was
used for detection.
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